Gary Park

R406, an Orally Available Spleen Tyrosine Kinase Inhibitor Blocks Fc Receptor Signaling and Reduces Immune Complex-Mediated Inflammation

Sylvia Braselmann, Vanessa Taylor, H. Zhao et al. · Journal of Pharmacology and Experimental Therapeutics · 2006 · 508 citations

Discovery of betrixaban (PRT054021), N-(5-chloropyridin-2-yl)-2-(4-(N,N-dimethylcarbamimidoyl)benzamido)-5-methoxybenzamide, a highly potent, selective, and orally efficacious factor Xa inhibitor

Penglie Zhang, Wenrong Huang, Lingyan Wang et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 105 citations · Full text

Medicinal Chemistry, Bioorganic Chemistry, Biochemistry +10

Metabolism of Fostamatinib, the Oral Methylene Phosphate Prodrug of the Spleen Tyrosine Kinase Inhibitor R406 in Humans: Contribution of Hepatic and Gut Bacterial Processes to the Overall Biotransformation

David J. Sweeny, Weiqun Li, Jeffrey Clough et al. · Drug Metabolism and Disposition · 2010 · 89 citations

The occurrence of the anti-cancer diterpene taxol in Podocarpus gracilior Pilger (Podocarpaceae)

Roy W. Stahlhut, Gary Park, Raymond L. Petersen et al. · Biochemical Systematics and Ecology · 1999 · 43 citations

Biology, Podocarpus Gracilior Pilger, Medicinal Chemistry +8

Exercise performance and peripheral vascular insufficiency improve with AMPK activation in high-fat diet-fed mice

Kristen A. Baltgalvis, Kathy White, Wei Li et al. · American Journal of Physiology-Heart and Circulatory Physiology · 2014 · 41 citations · Full text